Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

6 results
Display

Alteration of Lipid Profiles in Patients with Subclinical Hypothyroidism

Lee JE, Jeong SJ, Lee SJ, Lee YH, Lee Y, Lee SJ, Kim CH

OBJECTIVE: Overt hypothyroidism has been associated with abnormalities of lipid metabolism; however conflicting results regarding the degree of lipid changes in subclinical hypothyroidism (SCH) have been reported. The aim of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Statin Therapy with Coronary Plaque Imaging

Park JH

If there is coronary plaque, do we need statin therapy? Many studies have been conducted to answer this question. According to global guidelines, there is a high-risk patient population who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Double Right Coronary Arteries Originated from Separate Ostia with Total Occlusive Lesion in One of the Two Right Coronary Arteries

Chung J, Kim HL, Lim WH, Seo JB, Zo JH, Kim MA, Kim SH

Double right coronary arteries (RCA) are very rare congenital anomalies of coronary artery. We report a case of double RCA with total occlusion, incidentally found by collateral flows. A 71-year-old...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Novel Implication of Androgen in Diabetes-induced Alzheimer's Disease

Song J, Jung C, Kim OY

Alzheimer's disease (AD) is characterized by the accumulation of amyloid beta (Aβ) and the hyperphosphorylation of tau protein in the brain, leading to the increase in inflammation and neuronal loss....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Long-term Fenofibrate Therapy on Serum Creatinine and Its Reversibility in Hypertriglyceridemic Patients with Hypertension

Park GT, Jung M, Kim Y, Cho I, Won H, Shin SY, Lee WS, Lee KJ, Kim SW, Kim TH, Kim CJ

OBJECTIVE: Previous studies have shown that fenofibrate therapy increases serum creatinine level and that there is a return of serum creatinine to baseline level after the discontinuation of the drug....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Metabolic Syndrome Causes Cardiovascular Disease under Stable Statin Medication

Cho SC, Lee H, Nam HJ, Han KH

OBJECTIVE: Statins are known to prevent only 30–50% of cardiovascular disease(CVD) by reducing low-density lipoprotein cholesterol (LDL-C). There is a controversy about whether metabolic syndrome(MS) can increase the risk of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr